Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1421
Title: Impact of lunar phase on outcomes following ST‐elevation myocardial infarction.
Author: Segan, L.
Andrianopoulos, N.
Brennan, A.
Hiew, C.
Reid, C.
Oqueli, Ernesto
Ajani, A.
Clark, D .
Duffy, S.
Yip, T.
Issue Date: 2019
Conference Name: 67th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 13th Annual Australia and New Zealand Endovascular Therapies Meeting.
Conference Date: 8th - 11th August
Conference Place: Adelaide, Australia
Abstract: Background : There is a long-held belief in the association between the full moon and extremes of human behaviour and potential adverse health consequences. Small-scale studies are conflicting, however most suggest no clear association between lunar phase and occurrence of acute coronary syndromes. Methods: This multi-centre retrospective observational study from the Melbourne Intervention Group registry included 7,570 ST-elevation myocardial infarction (STEMI) cases from 6 tertiary centres over a 12-year study period in Victoria, Australia. Outcome measures: Primary outcomes studied included incidence of STEMI, major adverse cardiac and cerebrovascular events (MACCE) and mortality at 1 and 5 years in cases of ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention during the full moon between 2005–2017 in Victoria, Australia. Results: This study demonstrated no significant difference in STEMI incidence ( p = 0.61) nor of major adverse cardiovascular events across all lunar phases. Subgroup analysis confirmed no difference in outcomes during the full moon phase compared to a composite of other lunar phases. Kaplan-Meier survival estimates showed similar 30-day outcomes across lunar phases ( p = 0.35) and when comparing the full moon to a composite of other lunar phases ( p = 0.45). Similarly, there was no significant difference in survival at 1 and 5 years between lunar phases ( p = 0.68) or when comparing to the full moon phase ( p = 0.51). Conclusions: This study showed no significant difference in incidence, MACCE or survival outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention during the lunar phases.
URI: http://hdl.handle.net/11054/1421
Resource Link: https://doi.org/10.1111/imj.14413
Internal ID Number: 01372
Health Subject: LUNAR PHASE - FULL MOON
ADVERSE HEALTH CONDITIONS
ACUTE CORONARY SYNDROME
ST - ELEVATION MYOCARDIAL INFARCTION
PRIMARY PERCUTANEOUS CORONARY INTERVENTION
Type: Conference
Presentation
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.